| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | solifenacin succinate (Vesicare®) |
| Formulation | 5 mg and 10 mg film-coated tablet |
| Reference number | 281 |
| Indication | Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome |
| Company | Astellas Pharma Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 20/07/2004 |